Home » Topics » Regulatory

Regulatory
RSS

Chiron's Proleukin recommended for approval for new indication

Dec. 23, 1997

FDA clears Trovan, Pfizer's broad-spectrum quinolone

Dec. 22, 1997

Nutropin AQ also wins FDA approval

Dec. 19, 1997

Antizol cleared by FDA as first antidote for ethylene glycol poisoning

Dec. 19, 1997

Antiacne activity of oral contraceptives

Dec. 19, 1997

First biologic approved for treatment of diabetic foot ulcers

Dec. 18, 1997

Daiichi's Floxin receives FDA approval

Dec. 18, 1997

FDA approves Nutropin for GH deficiency in adults

Dec. 18, 1997

Indomethacin: antitumor activity and effects on telomerase

Dec. 17, 1997

Z-103 as effective as sulfasalazine in rat model of colitis

Dec. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...